These data support a role of the C3 and the AP axis in complement activation in severe COVID-19 either as a consequence of direct activation by SARS-CoV-2 or as an amplifier secondary to CP (and to a lesser degree LP) activation. This evidence concerns the gene C3 and COVID-19.